EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+20.95%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$6.13B
AUM Growth
+$6.13B
(+10%)
Cap. Flow
-$282M
Cap. Flow
% of AUM
-4.6%
Top 10 Holdings %
Top 10 Hldgs %
24.72%
Holding
175
New
20
Increased
64
Reduced
41
Closed
23
Top Buys
1 |
Celldex Therapeutics
CLDX
|
$80.5M |
2 |
Zentalis Pharmaceuticals
ZNTL
|
$56.8M |
3 |
Xometry
XMTR
|
$47.8M |
4 |
Lexeo Therapeutics
LXEO
|
$40.3M |
5 |
monday.com
MNDY
|
$38.4M |
Top Sells
1 |
Korro Bio
KRRO
|
$146M |
2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$79.8M |
3 |
Exact Sciences
EXAS
|
$58.1M |
4 |
Ascendis Pharma
ASND
|
$49.7M |
5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$47.4M |
Sector Composition
1 | Healthcare | 39.38% |
2 | Technology | 25.83% |
3 | Industrials | 16.87% |
4 | Consumer Discretionary | 8.76% |
5 | Energy | 2.25% |